Polymerized Type I Collagen Downregulates STAT-1 Phosphorylation Through Engagement with LAIR-1 in Circulating Monocytes, Avoiding Long COVID
Authors:
- Elizabeth Olivares-MartínezEOElizabeth Olivares-Martínez
- Diego Francisco Hernández-RamírezDHDiego Francisco Hernández-Ramírez
- Carlos Alberto Núñez-ÁlvarezCNCarlos Alberto Núñez-Álvarez
- David Eduardo Meza-SánchezDMDavid Eduardo Meza-Sánchez
- Mónica ChapaMCMónica Chapa
- Silvia Méndez-FloresSMSilvia Méndez-Flores
- Ángel Priego-RaneroÁPÁngel Priego-Ranero
- Daniel Azamar-LlamasDADaniel Azamar-Llamas
- Héctor Olvera-PradoHOHéctor Olvera-Prado
- Kenia Ilian Rivas-RedondaKRKenia Ilian Rivas-Redonda
- Eric Ochoa-HeinEOEric Ochoa-Hein
- Luis Gerardo López-MosquedaLLLuis Gerardo López-Mosqueda
Open Access
- 25 January 2025
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 26 (3) , 1018
Abstract
The intramuscular administration of polymerized type I collagen (PTIC) for adult symptomatic COVID-19 outpatients downregulated hyperinflammation and improved symptoms. We inferred that LAIR1 is a potential receptor for PTIC. Thus, a binding assay and surface plasmon resonance binding assay were performed to estimate the affinity of the interaction between LAIR1 and PTIC. M1 macrophages derived from THP-1 cells were cultured with 2–10% PTIC for 24 h. Lysates from PTIC-treated THP-1 cells, macrophage-like cells (MLCs), M1, M1 + IFN-γ, and M1 + LPS were analyzed by Western blot for NF-κB (p65), p38, STAT1, and pSTAT1 (tyrosine701). Serum cytokine levels and monocyte LAIR1 expressions (Mo1 and Mo2) were analyzed by luminometry and flow cytometry in symptomatic COVID-19 outpatients on PTIC treatment. PTIC-bound LAIR1 had a similar affinity to collagen in M1 macrophages. It downregulated pSTAT1 in IFN-γ-induced M1. COVID-19 patients under PTIC treatment showed a significant decrease in Mo1 percentages and cytokines (IP-10/MIF/eotaxin/IL-8/IL-1RA/M-CSF) associated with STAT1 and an increase in the Mo2 subset. The inflammatory mediators and Mo1 downregulation were related to better oxygen saturation and decreased dyspnea, chest pain, cough, and chronic fatigue syndrome in the acute and long-term phase of infection. PTIC is an agonist of LAIR1 and downregulates STAT-1 phosphorylation. PTIC could be relevant for treating STAT1-mediated inflammatory diseases, including COVID-19 and long COVID.Keywords
All Related Versions
Funding Information
- ASPID SA DE CV (INCMN/108/8/PI/047/2020)
This publication has 47 references indexed in Scilit:
- Effect of polymerised type I collagen on hyperinflammation of adult outpatients with symptomatic COVID‐19Clinical and Translational Medicine, 2022
- Comparison of semiquantitative chest CT scoring systems to estimate severity in coronavirus disease 2019 (COVID-19) pneumoniaEuropean Radiology, 2022
- Homeostatic functions of monocytes and interstitial lung macrophages are regulated via collagen domain-binding receptor LAIR1Immunity, 2021
- Silencing LAIR-1 in human THP-1 macrophage increases foam cell formation by modulating PPARγ and M2 polarizationCytokine, 2018
- LAIR-1 activation inhibits inflammatory macrophage phenotype in vitroCellular Immunology, 2018
- Towards integrating extracellular matrix and immunological pathwaysCytokine, 2017
- The role of LAIR-1 (CD305) in T cells and monocytes/macrophages in patients with rheumatoid arthritisCellular Immunology, 2014
- World Medical Association Declaration of HelsinkiJAMA, 2013
- Enhanced secretion of leukocyte-associated immunoglobulin-like receptor 2 (LAIR-2) and soluble LAIR-1 in rheumatoid arthritis: LAIR-2 is a more efficient antagonist of the LAIR-1-collagen inhibitory interaction than is soluble LAIR-1Arthritis & Rheumatism, 2011
- The value of C-reactive protein as a marker of systemic inflammation in stable chronic obstructive pulmonary diseaseEuropean Journal of Internal Medicine, 2008